Tel Aviv Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 3,
"returned": 3,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "b772fa09-f2d9-49fa-94d4-7ebd3fcdf5c9",
"title": "LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that LivePerson, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
"description": "SAN DIEGO —",
"keywords": "",
"snippet": "This advertisement has not loaded yet, but your article continues below.\n\nLPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that LivePerson, Inc....",
"url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/lpsn-investor-notice-robbins-geller-rudman-dowd-llp-announces-that-liveperson-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit",
"image_url": "https://dcs-static.gprod.postmedia.digital/15.0.1/websites/images/fp/favicon-fp.ico",
"language": "en",
"published_at": "2023-12-09T19:32:17.000000Z",
"source": "financialpost.com",
"relevance_score": null,
"entities": [
{
"symbol": "LPSN.TA",
"name": "LivePerson, Inc.",
"exchange": null,
"exchange_long": null,
"country": "il",
"type": "equity",
"industry": "Technology",
"match_score": 63.675858,
"sentiment_score": -0.085318,
"highlights": [
{
"highlight": "LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that <em>LivePerson</em>, <em>Inc</em>. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\n\nArticle content SAN DIEGO — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of <em>LivePerson</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>LivePerson</em>, <em>Inc</em>., No. 23-cv-10517 (S.D.N.Y.), the <em>LivePerson</em> class action lawsuit charges <em>LivePerson</em> and certain of its top executive officers with violations of the Securities Exchange Act of 1934.\n\nAdvertisement 2 Story continues below This advertisement has not loaded yet, but your article continues below.",
"sentiment": -0.3071,
"highlighted_in": "main_text"
},
{
"highlight": "Try refreshing your browser, or LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that <em>LivePerson</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Back to video If you suffered substantial losses and wish to serve as lead plaintiff of the <em>LivePerson</em> class action lawsuit, please provide your information here:\n\nArticle content https://www.rgrdlaw.com/cases-<em>liveperson</em>-<em>inc</em>-class-action-lpsn.html You can also contact attorney",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "CASE ALLEGATIONS: <em>LivePerson</em> delivers mobile and online messaging solutions through Conversational Artificial Intelligence. In February 2022, <em>LivePerson</em> acquired WildHealth, Inc., a precision medicine service, according to the complaint.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>LivePerson</em> class action lawsuit further alleges that on February 28, 2023, <em>LivePerson</em> revealed that, as a result of LivePerson’s acquisition of WildHealth, “[<em>LivePerson</em>] requires more time to perform additional review and testing of revenue recognition with respect to a recently discontinued WildHealth program, for which Medicare reimbursement is",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, the price of <em>LivePerson</em> stock fell more than 14%, according to the complaint.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>LivePerson</em> class action lawsuit alleges that on this news, the price of <em>LivePerson</em> stock fell nearly 7%.\n\nAdvertisement 3 Story continues below This advertisement has not loaded yet, but your article continues below.",
"sentiment": -0.1154,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>LivePerson</em> class action lawsuit alleges that on this news, the price of <em>LivePerson</em> stock fell nearly 58%.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "A lead plaintiff acts on behalf of all other class members in directing the <em>LivePerson</em> class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the <em>LivePerson</em> class action lawsuit.",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that <em>LivePerson</em>, <em>Inc</em>. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "717c82a9-fc36-47b3-905b-d883efcedf7a",
"title": "LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that LivePerson, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit -December 09, 2023 at 02:26 pm ES",
"description": "Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of LivePerson, Inc. securities between May 10, 2022 and March 16, 2023, both dates inclusive , have until January 30, 2024 to...",
"keywords": "Markets",
"snippet": "Official LIVEPERSON, INC. press release\n\nRobbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of LivePerson, Inc. (NASDAQ: LPSN) securities b...",
"url": "https://www.marketscreener.com/quote/stock/LIVEPERSON-INC-9909/news/LPSN-INVESTOR-NOTICE-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-LivePerson-Inc-Investors-wit-45537308/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
"language": "en",
"published_at": "2023-12-09T19:26:02.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "LPSN.TA",
"name": "LivePerson, Inc.",
"exchange": null,
"exchange_long": null,
"country": "il",
"type": "equity",
"industry": "Technology",
"match_score": 54.034786,
"sentiment_score": -0.093591,
"highlights": [
{
"highlight": "Official <em>LIVEPERSON</em>, <em>INC</em>. press release\n\nRobbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of <em>LivePerson</em>, <em>Inc</em>. (NASDAQ: LPSN) securities between May 10, 2022 and March 16, 2023, both dates inclusive (the “Class Period”), have until January 30, 2024 to seek appointment as lead plaintiff of the <em>LivePerson</em> class action lawsuit.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "<em>LivePerson</em>, <em>Inc</em>., No. 23-cv-10517 (S.D.N.Y.), the <em>LivePerson</em> class action lawsuit charges <em>LivePerson</em> and certain of its top executive officers with violations of the Securities Exchange Act of 1934.",
"sentiment": -0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered substantial losses and wish to serve as lead plaintiff of the <em>LivePerson</em> class action lawsuit, please provide your information here:\n\nhttps://www.rgrdlaw.com/cases-<em>liveperson</em>-<em>inc</em>-class-action-lpsn.html\n\nYou can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "CASE ALLEGATIONS: <em>LivePerson</em> delivers mobile and online messaging solutions through Conversational Artificial Intelligence. In February 2022, <em>LivePerson</em> acquired WildHealth, Inc., a precision medicine service, according to the complaint.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>LivePerson</em> class action lawsuit further alleges that on February 28, 2023, <em>LivePerson</em> revealed that, as a result of LivePerson’s acquisition of WildHealth, “[<em>LivePerson</em>] requires more time to perform additional review and testing of revenue recognition with respect to a recently discontinued WildHealth program, for which Medicare reimbursement is",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, the price of <em>LivePerson</em> stock fell more than 14%, according to the complaint.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>LivePerson</em> class action lawsuit alleges that on this news, the price of <em>LivePerson</em> stock fell nearly 7%.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "The <em>LivePerson</em> class action lawsuit alleges that on this news, the price of <em>LivePerson</em> stock fell nearly 58%.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired <em>LivePerson</em> securities during the Class Period to seek appointment as lead plaintiff of the <em>LivePerson</em> class action lawsuit.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "A lead plaintiff acts on behalf of all other class members in directing the <em>LivePerson</em> class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the <em>LivePerson</em> class action lawsuit.",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that <em>LivePerson</em>, <em>Inc</em>. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit -December 09, 2023 at 02:26 pm ES",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "c9a90995-1197-43af-8d7d-a2486b0d80a5",
"title": "Kamada: Kedrion Deal Locks In Growth (NASDAQ:KMDA)",
"description": "Kamada, a profitable specialty plasma company, secures long-term growth with an expanded commercial deal for its anti-rabies drug. Learn more on KMDA stock here.",
"keywords": "",
"snippet": "FluxFactory/E+ via Getty Images\n\nI recently wrote an article outlining the investment case for Kamada Ltd. (NASDAQ:KMDA), a small manufacturer of plasma-based p...",
"url": "https://seekingalpha.com/article/4656947-kamada-kedrion-deal-locks-in-growth",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1463489972/image_1463489972.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2023-12-08T23:42:29.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "KMDA.TA",
"name": "Kamada Ltd.",
"exchange": null,
"exchange_long": null,
"country": "il",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.857857,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "FluxFactory/E+ via Getty Images\n\nI recently wrote an article outlining the investment case for <em>Kamada</em> <em>Ltd</em>. (NASDAQ:KMDA), a small manufacturer of plasma-based pharmaceuticals. This is an unexpectedly quick update following Kamada's announcement of a major commercial agreement.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "TLV",
"total_documents": 3,
"sentiment_avg": 0.10499700158834457
}
]
}
Other details
Country
- il
- 1,096